Prosecution Insights
Last updated: April 19, 2026

UNIVERSITE CATHOLIQUE DE LOUVAIN

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18580828 PREVENTION AND/OR TREATMENT OF REWARD DYSREGULATION DISORDERS HAUK TEODORO, PRICILA NMN 1645 Non-Final OA Jan 19, 2024
17920116 ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER DAVIS, BRIAN J 1614 Non-Final OA Oct 20, 2022
17792011 GENETICALLY MODIFIED BACTERIUM WITH ALTERED ENVELOP INTEGRITY AND USES THEREOF STEADMAN, DAVID J 1656 Non-Final OA Jul 11, 2022
17608002 LACTATE DEHYDROGENASE INHIBITOR POLYPEPTIDES FOR USE IN THE TREATMENT OF CANCER ROONEY, NORA MAUREEN 1641 Final Rejection Nov 01, 2021

Managing UNIVERSITE CATHOLIQUE DE LOUVAIN's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month